china glp-1 has approved Pfizer's treatment ​Xianweiying for long-term weight management in overweight or ‌obese adults, the U.S. drugmaker said, opens new tab on WeChat on Friday, boosting competition in a market China approves popular weight-loss drug

Common side effects include: Nausea Vomiting Diarrhea Stomach pain Constipation Reduced appetite More serious risks may involve: Thyroid concerns Pancreatitis Gallbladder issues Vision changes Severe gastrointestinal (GI) complications Allergic reactions A healthcare provider should review your medical history before starting treatment

API source: Active ingredient must come from an FDA-registered facility

What Is a GLP-1

FDA-approved GLP-1 medicationslike the new Wegovy pillhelp control appetite and blood sugar for sustainable weight loss

Stress management Chronic stress elevates cortisol, which promotes abdominal fat storage and increases appetite for high-calorie comfort foods